Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)
Clinical trial NCT00923169 · COMPLETED
Trial details
- NCT number
- NCT00923169
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-09
- Primary completion
- 2010-01-20
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.